Skip to content

Scientists find possible topical treatment for skin lesions

BOSTON, Jan. 29 (UPI) — Researchers at Harvard University found that blocking specific signaling enzymes that contribute to common benign skin lesions called seborrheic keratoses, or SKs, cause them die, according to a new study.

The researchers, who work at Massachusetts General Hospital, were investigating why the lesions, which have genetic similarities to cancer, grow but never turn cancerous.

Previous research has identified genes thought to be involved with differentiation between skin cells and skin cancer development. Two genes that code for proteins activating the Akt kinase enzyme, known to block cell-death related pathways, leading researchers to see what happens when the kinase is blocked.